Home › Librede Receives Phase I SBIR To Develop Yeast-Based Cannabinoid Production And Drug Discovery Platform
 

Keywords :   


Librede Receives Phase I SBIR To Develop Yeast-Based Cannabinoid Production And Drug Discovery Platform

2016-03-30 06:19:04| drugdiscoveryonline Home Page

Librede, a biotechnology company specializing in yeast-based cannabinoid production, announced that it has received a Small Business Innovative Research (SBIR) grant from the National Center for Complementary & Integrative Health (NCCIH) of the National Institutes of Health (NIH)

Tags: production develop drug phase

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
26.06Eastern North Pacific Tropical Weather Outlook
26.06Atlantic Tropical Weather Outlook
26.06VW to invest up to $5bn in Tesla rival Rivian
26.06Strategic use of soybean meal to maximize hog carcass weight during summer
26.06Eastern North Pacific Tropical Weather Outlook
26.06Atlantic Tropical Weather Outlook
26.06Aer Lingus pilots begin industrial action over pay dispute
25.06Water requirements in the summer
More »